FIELD: medicine.
SUBSTANCE: invention relates to a method of treating glioblastoma in a subject by administering a therapeutically effective amount of an antibody or antigen-binding portion thereof, which specifically binds to the programmed death-1 receptor (PD-1) and inhibits PD-1 ("anti-PD-1"), and temozolomide activity.
EFFECT: method enables higher clinical effectiveness in glioblastoma ensured by a synergistic effect of the combination.
53 cl, 17 dwg, 1 tbl, 10 ex
| Title |
Year |
Author |
Number |
| TREATING LUNG CANCER BY COMBINATION OF ANTI-PD-1 AND OTHER ANTI-CANCER AGENTS |
2015 |
- Feltquate David
- Chen Allen C.
|
RU2695332C2 |
| ANTIBODIES AGAINST PD-1 FOR TREATMENT OF LUNG CANCER |
2018 |
- Rietschel, Petra
- Lowy, Israel
|
RU2771759C2 |
| CONTROL POINT INHIBITOR AND WHOLE MYCOBACTERIAL CELLS FOR USE IN CANCER THERAPY |
2016 |
- Akle Charles
- Brunet Laura Rosa
|
RU2733033C2 |
| ANTIBODIES TO B7-H1 AND TO CTLA-4 FOR TREATING NON-SMALL-CELL LUNG CANCER |
2015 |
- Narwal, Rajesh
- Robbins, Paul
- Karakunnel, Joyson
- Dar, Mohammed M.
|
RU2702332C2 |
| NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2711380C2 |
| NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2817047C2 |
| TREATING SYD985 PATIENTS WITH T-DM1 REFRACTORY CANCER |
2016 |
- Vortman, Gerrit
- Koper, Norbert Peter
|
RU2728101C2 |
| CONTROL POINT INHIBITOR AND WHOLE-CELL MICROBACTERIA FOR USE IN TREATING ONCOLOGICAL DISEASE |
2014 |
- Ekl Charlz
- Grendzh Dzhon
- Bilyard Kevin
|
RU2719934C2 |
| METHODS OF TREATING CANCER USING ANTI-PD-1 ANTIBODIES AND ANTI-CTLA4 ANTIBODIES |
2019 |
- Lala, Mallika
- Dzhejn, Lokesh
- Li, Mengiao
- Altura, Rejchel Ellison
- Tse, Archi Ngaj-Chiu
|
RU2825835C2 |
| PD-1/PD-L1 INHIBITORS FOR TREATING CANCER |
2016 |
- Cuillerot Jean-Marie
- Heydebreck Anja Von
- Yuan Guojun
|
RU2742312C1 |
